呼吸器治療薬の世界市場 2023-2027

呼吸器治療薬市場は2022-2027年に302億3,000万米ドル、予測期間中のCAGRは6.38%で成長すると予測されています。

当レポートでは、呼吸器治療薬市場の全体的な分析、市場規模・予測、動向、成長促進要因、課題、約25のベンダーを網羅したベンダー分析などを掲載しています。

現在の市場シナリオ、最新動向と促進要因、市場環境全体に関する最新分析を提供しています。市場は、持続可能で安全な呼吸器治療薬の必要性、呼吸器疾患の有病率の上昇、タバコ消費の増加によって牽引されています。

本調査では、今後数年間の呼吸器治療薬市場成長を牽引する主な要因の1つとして、遠隔医療と遠隔モニタリングの台頭を挙げています。また、生物学的製剤や標的治療の採用、デジタルヘルス統合の高まりは、同市場の大きな需要につながります。

目次

第1章 エグゼクティブサマリー

• 市場概要

第2章 市場情勢

• 市場エコシステム

第3章 市場規模

• 市場の定義
• 市場セグメント分析
• 市場規模 2022
• 市場の見通し 2022-2027

第4章 市場規模実績

• 呼吸器治療薬の世界市場 2017-2021
• 流通チャネル別セグメント分析 2017-2021
• タイプ別セグメント分析 2017-2021
• 地域別セグメント分析 2017-2021
• 国別セグメント分析 2017-2021

第5章 ファイブフォース分析

• ファイブフォースの要約
• 買い手の交渉力
• 供給企業の交渉力
• 新規参入業者の脅威
• 代替品の脅威
• 競争の脅威
• 市況

第6章 市場セグメンテーション：流通チャネル別

• 市場セグメント
• 比較：流通チャネル別
• 病院薬局：市場規模と予測 2022-2027
• 小売薬局：市場規模と予測 2022-2027
• オンライン薬局：市場規模と予測 2022-2027
• 市場機会：流通チャネル別

第7章 市場セグメンテーション：タイプ別

• 市場セグメント
• 比較：タイプ別
• 喘息：市場規模と予測 2022-2027
• COPD：市場規模と予測 2022-2027
• アレルギー性鼻炎：市場規模と予測 2022-2027
• 嚢胞性線維症：市場規模と予測 2022-2027
• その他の呼吸器疾患：市場規模と予測 2022-2027
• 市場機会：タイプ別

第8章 顧客情勢

• 顧客情勢の概要

第9章 地域別情勢

• 地域別セグメンテーション
• 地域別比較
• 北米：市場規模と予測 2022-2027
• 欧州：市場規模と予測 2022-2027
• アジア：市場規模と予測 2022-2027
• 世界のその他の地域：市場規模と予測 2022-2027
• 米国：市場規模と予測 2022-2027
• ドイツ：市場規模と予測 2022-2027
• カナダ：市場規模と予測 2022-2027
• 中国：市場規模と予測 2022-2027
• 英国：市場規模と予測 2022-2027
• 市場機会：地域情勢別

第10章 促進要因、課題、および動向

• 市場促進要因
• 市場の課題
• 促進要因と課題の影響
• 市場動向

第11章 ベンダー情勢

• 概要
• ベンダー情勢
• 混乱の状況
• 業界のリスク

第12章 ベンダー分析

• 対象ベンダー
• ベンダーの市場ポジショニング
• Abbott Laboratories
• AbbVie Inc.
• Aerogen Pharma Ltd.
• AstraZeneca Plc
• Boehringer Ingelheim International GmbH
• Celon Pharma SA
• Cipla Ltd.
• F. Hoffmann La Roche Ltd.
• GlaxoSmithKline Plc
• Glenmark Pharmaceuticals Ltd.
• Lupin Ltd.
• Novartis AG
• Sumitomo Pharma Co. Ltd.
• Teva Pharmaceutical Industries Ltd.
• Vertex Pharmaceuticals Inc.

第13章 付録

Exhibits:

• Exhibits1: Executive Summary - Chart on Market Overview
• Exhibits2: Executive Summary - Data Table on Market Overview
• Exhibits3: Executive Summary - Chart on Global Market Characteristics
• Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
• Exhibits5: Executive Summary - Chart on Market Segmentation by Distribution Channel
• Exhibits6: Executive Summary - Chart on Market Segmentation by Type
• Exhibits7: Executive Summary - Chart on Incremental Growth
• Exhibits8: Executive Summary - Data Table on Incremental Growth
• Exhibits9: Executive Summary - Chart on Vendor Market Positioning
• Exhibits10: Parent market
• Exhibits11: Market Characteristics
• Exhibits12: Offerings of vendors included in the market definition
• Exhibits13: Market segments
• Exhibits14: Chart on Global - Market size and forecast 2022-2027 ($ billion)
• Exhibits15: Data Table on Global - Market size and forecast 2022-2027 ($ billion)
• Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
• Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
• Exhibits18: Historic Market Size - Data Table on global respiratory drugs market 2017 - 2021 ($ billion)
• Exhibits19: Historic Market Size - Distribution Channel Segment 2017 - 2021 ($ billion)
• Exhibits20: Historic Market Size - Type Segment 2017 - 2021 ($ billion)
• Exhibits21: Historic Market Size - Geography Segment 2017 - 2021 ($ billion)
• Exhibits22: Historic Market Size - Country Segment 2017 - 2021 ($ billion)
• Exhibits23: Five forces analysis - Comparison between 2022 and 2027
• Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
• Exhibits25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
• Exhibits26: Threat of new entrants - Impact of key factors in 2022 and 2027
• Exhibits27: Threat of substitutes - Impact of key factors in 2022 and 2027
• Exhibits28: Threat of rivalry - Impact of key factors in 2022 and 2027
• Exhibits29: Chart on Market condition - Five forces 2022 and 2027
• Exhibits30: Chart on Distribution Channel - Market share 2022-2027 (%)
• Exhibits31: Data Table on Distribution Channel - Market share 2022-2027 (%)
• Exhibits32: Chart on Comparison by Distribution Channel
• Exhibits33: Data Table on Comparison by Distribution Channel
• Exhibits34: Chart on Hospital pharmacies - Market size and forecast 2022-2027 ($ billion)
• Exhibits35: Data Table on Hospital pharmacies - Market size and forecast 2022-2027 ($ billion)
• Exhibits36: Chart on Hospital pharmacies - Year-over-year growth 2022-2027 (%)
• Exhibits37: Data Table on Hospital pharmacies - Year-over-year growth 2022-2027 (%)
• Exhibits38: Chart on Retail pharmacies - Market size and forecast 2022-2027 ($ billion)
• Exhibits39: Data Table on Retail pharmacies - Market size and forecast 2022-2027 ($ billion)
• Exhibits40: Chart on Retail pharmacies - Year-over-year growth 2022-2027 (%)
• Exhibits41: Data Table on Retail pharmacies - Year-over-year growth 2022-2027 (%)
• Exhibits42: Chart on Online pharmacies - Market size and forecast 2022-2027 ($ billion)
• Exhibits43: Data Table on Online pharmacies - Market size and forecast 2022-2027 ($ billion)
• Exhibits44: Chart on Online pharmacies - Year-over-year growth 2022-2027 (%)
• Exhibits45: Data Table on Online pharmacies - Year-over-year growth 2022-2027 (%)
• Exhibits46: Market opportunity by Distribution Channel ($ billion)
• Exhibits47: Data Table on Market opportunity by Distribution Channel ($ billion)
• Exhibits48: Chart on Type - Market share 2022-2027 (%)
• Exhibits49: Data Table on Type - Market share 2022-2027 (%)
• Exhibits50: Chart on Comparison by Type
• Exhibits51: Data Table on Comparison by Type
• Exhibits52: Chart on Asthma - Market size and forecast 2022-2027 ($ billion)
• Exhibits53: Data Table on Asthma - Market size and forecast 2022-2027 ($ billion)
• Exhibits54: Chart on Asthma - Year-over-year growth 2022-2027 (%)
• Exhibits55: Data Table on Asthma - Year-over-year growth 2022-2027 (%)
• Exhibits56: Chart on COPD - Market size and forecast 2022-2027 ($ billion)
• Exhibits57: Data Table on COPD - Market size and forecast 2022-2027 ($ billion)
• Exhibits58: Chart on COPD - Year-over-year growth 2022-2027 (%)
• Exhibits59: Data Table on COPD - Year-over-year growth 2022-2027 (%)
• Exhibits60: Chart on Allergic rhinitis - Market size and forecast 2022-2027 ($ billion)
• Exhibits61: Data Table on Allergic rhinitis - Market size and forecast 2022-2027 ($ billion)
• Exhibits62: Chart on Allergic rhinitis - Year-over-year growth 2022-2027 (%)
• Exhibits63: Data Table on Allergic rhinitis - Year-over-year growth 2022-2027 (%)
• Exhibits64: Chart on Cystic fibrosis - Market size and forecast 2022-2027 ($ billion)
• Exhibits65: Data Table on Cystic fibrosis - Market size and forecast 2022-2027 ($ billion)
• Exhibits66: Chart on Cystic fibrosis - Year-over-year growth 2022-2027 (%)
• Exhibits67: Data Table on Cystic fibrosis - Year-over-year growth 2022-2027 (%)
• Exhibits68: Chart on Other respiratory diseases - Market size and forecast 2022-2027 ($ billion)
• Exhibits69: Data Table on Other respiratory diseases - Market size and forecast 2022-2027 ($ billion)
• Exhibits70: Chart on Other respiratory diseases - Year-over-year growth 2022-2027 (%)
• Exhibits71: Data Table on Other respiratory diseases - Year-over-year growth 2022-2027 (%)
• Exhibits72: Market opportunity by Type ($ billion)
• Exhibits73: Data Table on Market opportunity by Type ($ billion)
• Exhibits74: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• Exhibits75: Chart on Market share By Geographical Landscape 2022-2027 (%)
• Exhibits76: Data Table on Market share By Geographical Landscape 2022-2027 (%)
• Exhibits77: Chart on Geographic comparison
• Exhibits78: Data Table on Geographic comparison
• Exhibits79: Chart on North America - Market size and forecast 2022-2027 ($ billion)
• Exhibits80: Data Table on North America - Market size and forecast 2022-2027 ($ billion)
• Exhibits81: Chart on North America - Year-over-year growth 2022-2027 (%)
• Exhibits82: Data Table on North America - Year-over-year growth 2022-2027 (%)
• Exhibits83: Chart on Europe - Market size and forecast 2022-2027 ($ billion)
• Exhibits84: Data Table on Europe - Market size and forecast 2022-2027 ($ billion)
• Exhibits85: Chart on Europe - Year-over-year growth 2022-2027 (%)
• Exhibits86: Data Table on Europe - Year-over-year growth 2022-2027 (%)
• Exhibits87: Chart on Asia - Market size and forecast 2022-2027 ($ billion)
• Exhibits88: Data Table on Asia - Market size and forecast 2022-2027 ($ billion)
• Exhibits89: Chart on Asia - Year-over-year growth 2022-2027 (%)
• Exhibits90: Data Table on Asia - Year-over-year growth 2022-2027 (%)
• Exhibits91: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
• Exhibits92: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
• Exhibits93: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
• Exhibits94: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
• Exhibits95: Chart on US - Market size and forecast 2022-2027 ($ billion)
• Exhibits96: Data Table on US - Market size and forecast 2022-2027 ($ billion)
• Exhibits97: Chart on US - Year-over-year growth 2022-2027 (%)
• Exhibits98: Data Table on US - Year-over-year growth 2022-2027 (%)
• Exhibits99: Chart on Germany - Market size and forecast 2022-2027 ($ billion)
• Exhibits100: Data Table on Germany - Market size and forecast 2022-2027 ($ billion)
• Exhibits101: Chart on Germany - Year-over-year growth 2022-2027 (%)
• Exhibits102: Data Table on Germany - Year-over-year growth 2022-2027 (%)
• Exhibits103: Chart on Canada - Market size and forecast 2022-2027 ($ billion)
• Exhibits104: Data Table on Canada - Market size and forecast 2022-2027 ($ billion)
• Exhibits105: Chart on Canada - Year-over-year growth 2022-2027 (%)
• Exhibits106: Data Table on Canada - Year-over-year growth 2022-2027 (%)
• Exhibits107: Chart on China - Market size and forecast 2022-2027 ($ billion)
• Exhibits108: Data Table on China - Market size and forecast 2022-2027 ($ billion)
• Exhibits109: Chart on China - Year-over-year growth 2022-2027 (%)
• Exhibits110: Data Table on China - Year-over-year growth 2022-2027 (%)
• Exhibits111: Chart on UK - Market size and forecast 2022-2027 ($ billion)
• Exhibits112: Data Table on UK - Market size and forecast 2022-2027 ($ billion)
• Exhibits113: Chart on UK - Year-over-year growth 2022-2027 (%)
• Exhibits114: Data Table on UK - Year-over-year growth 2022-2027 (%)
• Exhibits115: Market opportunity By Geographical Landscape ($ billion)
• Exhibits116: Data Tables on Market opportunity By Geographical Landscape ($ billion)
• Exhibits117: Impact of drivers and challenges in 2022 and 2027
• Exhibits118: Overview on Criticality of inputs and Factors of differentiation
• Exhibits119: Overview on factors of disruption
• Exhibits120: Impact of key risks on business
• Exhibits121: Vendors covered
• Exhibits122: Matrix on vendor position and classification
• Exhibits123: Abbott Laboratories - Overview
• Exhibits124: Abbott Laboratories - Business segments
• Exhibits125: Abbott Laboratories - Key news
• Exhibits126: Abbott Laboratories - Key offerings
• Exhibits127: Abbott Laboratories - Segment focus
• Exhibits128: AbbVie Inc. - Overview
• Exhibits129: AbbVie Inc. - Product / Service
• Exhibits130: AbbVie Inc. - Key news
• Exhibits131: AbbVie Inc. - Key offerings
• Exhibits132: Aerogen Pharma Ltd. - Overview
• Exhibits133: Aerogen Pharma Ltd. - Product / Service
• Exhibits134: Aerogen Pharma Ltd. - Key offerings
• Exhibits135: AstraZeneca Plc - Overview
• Exhibits136: AstraZeneca Plc - Product / Service
• Exhibits137: AstraZeneca Plc - Key news
• Exhibits138: AstraZeneca Plc - Key offerings
• Exhibits139: Boehringer Ingelheim International GmbH - Overview
• Exhibits140: Boehringer Ingelheim International GmbH - Business segments
• Exhibits141: Boehringer Ingelheim International GmbH - Key news
• Exhibits142: Boehringer Ingelheim International GmbH - Key offerings
• Exhibits143: Boehringer Ingelheim International GmbH - Segment focus
• Exhibits144: Celon Pharma SA - Overview
• Exhibits145: Celon Pharma SA - Business segments
• Exhibits146: Celon Pharma SA - Key offerings
• Exhibits147: Celon Pharma SA - Segment focus
• Exhibits148: Cipla Ltd. - Overview
• Exhibits149: Cipla Ltd. - Business segments
• Exhibits150: Cipla Ltd. - Key news
• Exhibits151: Cipla Ltd. - Key offerings
• Exhibits152: Cipla Ltd. - Segment focus
• Exhibits153: F. Hoffmann La Roche Ltd. - Overview
• Exhibits154: F. Hoffmann La Roche Ltd. - Business segments
• Exhibits155: F. Hoffmann La Roche Ltd. - Key news
• Exhibits156: F. Hoffmann La Roche Ltd. - Key offerings
• Exhibits157: F. Hoffmann La Roche Ltd. - Segment focus
• Exhibits158: GlaxoSmithKline Plc - Overview
• Exhibits159: GlaxoSmithKline Plc - Business segments
• Exhibits160: GlaxoSmithKline Plc - Key news
• Exhibits161: GlaxoSmithKline Plc - Key offerings
• Exhibits162: GlaxoSmithKline Plc - Segment focus
• Exhibits163: Glenmark Pharmaceuticals Ltd. - Overview
• Exhibits164: Glenmark Pharmaceuticals Ltd. - Product / Service
• Exhibits165: Glenmark Pharmaceuticals Ltd. - Key offerings
• Exhibits166: Lupin Ltd. - Overview
• Exhibits167: Lupin Ltd. - Product / Service
• Exhibits168: Lupin Ltd. - Key news
• Exhibits169: Lupin Ltd. - Key offerings
• Exhibits170: Novartis AG - Overview
• Exhibits171: Novartis AG - Business segments
• Exhibits172: Novartis AG - Key offerings
• Exhibits173: Novartis AG - Segment focus
• Exhibits174: Sumitomo Pharma Co. Ltd. - Overview
• Exhibits175: Sumitomo Pharma Co. Ltd. - Business segments
• Exhibits176: Sumitomo Pharma Co. Ltd. - Key offerings
• Exhibits177: Sumitomo Pharma Co. Ltd. - Segment focus
• Exhibits178: Teva Pharmaceutical Industries Ltd. - Overview
• Exhibits179: Teva Pharmaceutical Industries Ltd. - Business segments
• Exhibits180: Teva Pharmaceutical Industries Ltd. - Key news
• Exhibits181: Teva Pharmaceutical Industries Ltd. - Key offerings
• Exhibits182: Teva Pharmaceutical Industries Ltd. - Segment focus
• Exhibits183: Vertex Pharmaceuticals Inc. - Overview
• Exhibits184: Vertex Pharmaceuticals Inc. - Product / Service
• Exhibits185: Vertex Pharmaceuticals Inc. - Key offerings
• Exhibits186: Inclusions checklist
• Exhibits187: Exclusions checklist
• Exhibits188: Currency conversion rates for US$
• Exhibits189: Research methodology
• Exhibits190: Validation techniques employed for market sizing
• Exhibits191: Information sources
• Exhibits192: List of abbreviations

The respiratory drugs market is forecasted to grow by USD 30.23 bn during 2022-2027, accelerating at a CAGR of 6.38% during the forecast period. The report on the respiratory drugs market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by need for sustainable and safe respiratory drugs, rising prevalence of respiratory diseases, and increasing tobacco consumption.

Technavio's respiratory drugs market is segmented as below:

By Distribution Channel

• Hospital pharmacies
• Retail pharmacies
• Online pharmacies

By Type

• Asthma
• COPD
• Allergic rhinitis
• Cystic fibrosis
• Other respiratory diseases

By Geographical Landscape

• North America
• Europe
• Asia
• Rest of World (ROW)

This study identifies the emergence of telehealth and remote monitoring as one of the prime reasons driving the respiratory drugs market growth during the next few years. Also, adoption of biologics and targeted therapies and rising digital health integration will lead to sizable demand in the market.

The report on the respiratory drugs market covers the following areas:

• Respiratory drugs market sizing
• Respiratory drugs market forecast
• Respiratory drugs market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading respiratory drugs market vendors that include Abbott Laboratories, AbbVie Inc., Aerogen Pharma Ltd., AstraZeneca Plc, Aurobindo Pharma Ltd., Boehringer Ingelheim International GmbH, Celon Pharma SA, Cipla Ltd., F. Hoffmann La Roche Ltd., GlaxoSmithKline Plc, Laboratory Corp. of America Holdings, Lupin Ltd., Medisol Lifescience Pvt. Ltd., Merck and Co. Inc., Novartis AG, Sumitomo Pharma Co. Ltd., Teva Pharmaceutical Industries Ltd., Vertex Pharmaceuticals Inc., Wellona Pharma, and Glenmark Pharmaceuticals Ltd.. Also, the respiratory drugs market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview
• Exhibit 01: Executive Summary - Chart on Market Overview
• Exhibit 02: Executive Summary - Data Table on Market Overview
• Exhibit 03: Executive Summary - Chart on Global Market Characteristics
• Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
• Exhibit 05: Executive Summary - Chart on Market Segmentation by Distribution Channel
• Exhibit 06: Executive Summary - Chart on Market Segmentation by Type
• Exhibit 07: Executive Summary - Chart on Incremental Growth
• Exhibit 08: Executive Summary - Data Table on Incremental Growth
• Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

• 2.1 Market ecosystem
• Exhibit 10: Parent market
• Exhibit 11: Market Characteristics

3 Market Sizing

• 3.1 Market definition
• Exhibit 12: Offerings of vendors included in the market definition
• 3.2 Market segment analysis
• Exhibit 13: Market segments
• 3.3 Market size 2022
• 3.4 Market outlook: Forecast for 2022-2027
• Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ billion)
• Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ billion)
• Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
• Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

4 Historic Market Size

• 4.1 Global respiratory drugs market 2017 - 2021
• Exhibit 18: Historic Market Size - Data Table on global respiratory drugs market 2017 - 2021 ($ billion)
• 4.2 Distribution Channel Segment Analysis 2017 - 2021
• Exhibit 19: Historic Market Size - Distribution Channel Segment 2017 - 2021 ($ billion)
• 4.3 Type Segment Analysis 2017 - 2021
• Exhibit 20: Historic Market Size - Type Segment 2017 - 2021 ($ billion)
• 4.4 Geography Segment Analysis 2017 - 2021
• Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ billion)
• 4.5 Country Segment Analysis 2017 - 2021
• Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ billion)

5 Five Forces Analysis

• 5.1 Five forces summary
• Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
• 5.2 Bargaining power of buyers
• Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
• 5.3 Bargaining power of suppliers
• Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
• 5.4 Threat of new entrants
• Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
• 5.5 Threat of substitutes
• Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
• 5.6 Threat of rivalry
• Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
• 5.7 Market condition
• Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

6 Market Segmentation by Distribution Channel

• 6.1 Market segments
• Exhibit 30: Chart on Distribution Channel - Market share 2022-2027 (%)
• Exhibit 31: Data Table on Distribution Channel - Market share 2022-2027 (%)
• 6.2 Comparison by Distribution Channel
• Exhibit 32: Chart on Comparison by Distribution Channel
• Exhibit 33: Data Table on Comparison by Distribution Channel
• 6.3 Hospital pharmacies - Market size and forecast 2022-2027
• Exhibit 34: Chart on Hospital pharmacies - Market size and forecast 2022-2027 ($ billion)
• Exhibit 35: Data Table on Hospital pharmacies - Market size and forecast 2022-2027 ($ billion)
• Exhibit 36: Chart on Hospital pharmacies - Year-over-year growth 2022-2027 (%)
• Exhibit 37: Data Table on Hospital pharmacies - Year-over-year growth 2022-2027 (%)
• 6.4 Retail pharmacies - Market size and forecast 2022-2027
• Exhibit 38: Chart on Retail pharmacies - Market size and forecast 2022-2027 ($ billion)
• Exhibit 39: Data Table on Retail pharmacies - Market size and forecast 2022-2027 ($ billion)
• Exhibit 40: Chart on Retail pharmacies - Year-over-year growth 2022-2027 (%)
• Exhibit 41: Data Table on Retail pharmacies - Year-over-year growth 2022-2027 (%)
• 6.5 Online pharmacies - Market size and forecast 2022-2027
• Exhibit 42: Chart on Online pharmacies - Market size and forecast 2022-2027 ($ billion)
• Exhibit 43: Data Table on Online pharmacies - Market size and forecast 2022-2027 ($ billion)
• Exhibit 44: Chart on Online pharmacies - Year-over-year growth 2022-2027 (%)
• Exhibit 45: Data Table on Online pharmacies - Year-over-year growth 2022-2027 (%)
• 6.6 Market opportunity by Distribution Channel
• Exhibit 46: Market opportunity by Distribution Channel ($ billion)
• Exhibit 47: Data Table on Market opportunity by Distribution Channel ($ billion)

7 Market Segmentation by Type

• 7.1 Market segments
• Exhibit 48: Chart on Type - Market share 2022-2027 (%)
• Exhibit 49: Data Table on Type - Market share 2022-2027 (%)
• 7.2 Comparison by Type
• Exhibit 50: Chart on Comparison by Type
• Exhibit 51: Data Table on Comparison by Type
• 7.3 Asthma - Market size and forecast 2022-2027
• Exhibit 52: Chart on Asthma - Market size and forecast 2022-2027 ($ billion)
• Exhibit 53: Data Table on Asthma - Market size and forecast 2022-2027 ($ billion)
• Exhibit 54: Chart on Asthma - Year-over-year growth 2022-2027 (%)
• Exhibit 55: Data Table on Asthma - Year-over-year growth 2022-2027 (%)
• 7.4 COPD - Market size and forecast 2022-2027
• Exhibit 56: Chart on COPD - Market size and forecast 2022-2027 ($ billion)
• Exhibit 57: Data Table on COPD - Market size and forecast 2022-2027 ($ billion)
• Exhibit 58: Chart on COPD - Year-over-year growth 2022-2027 (%)
• Exhibit 59: Data Table on COPD - Year-over-year growth 2022-2027 (%)
• 7.5 Allergic rhinitis - Market size and forecast 2022-2027
• Exhibit 60: Chart on Allergic rhinitis - Market size and forecast 2022-2027 ($ billion)
• Exhibit 61: Data Table on Allergic rhinitis - Market size and forecast 2022-2027 ($ billion)
• Exhibit 62: Chart on Allergic rhinitis - Year-over-year growth 2022-2027 (%)
• Exhibit 63: Data Table on Allergic rhinitis - Year-over-year growth 2022-2027 (%)
• 7.6 Cystic fibrosis - Market size and forecast 2022-2027
• Exhibit 64: Chart on Cystic fibrosis - Market size and forecast 2022-2027 ($ billion)
• Exhibit 65: Data Table on Cystic fibrosis - Market size and forecast 2022-2027 ($ billion)
• Exhibit 66: Chart on Cystic fibrosis - Year-over-year growth 2022-2027 (%)
• Exhibit 67: Data Table on Cystic fibrosis - Year-over-year growth 2022-2027 (%)
• 7.7 Other respiratory diseases - Market size and forecast 2022-2027
• Exhibit 68: Chart on Other respiratory diseases - Market size and forecast 2022-2027 ($ billion)
• Exhibit 69: Data Table on Other respiratory diseases - Market size and forecast 2022-2027 ($ billion)
• Exhibit 70: Chart on Other respiratory diseases - Year-over-year growth 2022-2027 (%)
• Exhibit 71: Data Table on Other respiratory diseases - Year-over-year growth 2022-2027 (%)
• 7.8 Market opportunity by Type
• Exhibit 72: Market opportunity by Type ($ billion)
• Exhibit 73: Data Table on Market opportunity by Type ($ billion)

8 Customer Landscape

• 8.1 Customer landscape overview
• Exhibit 74: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

• 9.1 Geographic segmentation
• Exhibit 75: Chart on Market share By Geographical Landscape 2022-2027 (%)
• Exhibit 76: Data Table on Market share By Geographical Landscape 2022-2027 (%)
• 9.2 Geographic comparison
• Exhibit 77: Chart on Geographic comparison
• Exhibit 78: Data Table on Geographic comparison
• 9.3 North America - Market size and forecast 2022-2027
• Exhibit 79: Chart on North America - Market size and forecast 2022-2027 ($ billion)
• Exhibit 80: Data Table on North America - Market size and forecast 2022-2027 ($ billion)
• Exhibit 81: Chart on North America - Year-over-year growth 2022-2027 (%)
• Exhibit 82: Data Table on North America - Year-over-year growth 2022-2027 (%)
• 9.4 Europe - Market size and forecast 2022-2027
• Exhibit 83: Chart on Europe - Market size and forecast 2022-2027 ($ billion)
• Exhibit 84: Data Table on Europe - Market size and forecast 2022-2027 ($ billion)
• Exhibit 85: Chart on Europe - Year-over-year growth 2022-2027 (%)
• Exhibit 86: Data Table on Europe - Year-over-year growth 2022-2027 (%)
• 9.5 Asia - Market size and forecast 2022-2027
• Exhibit 87: Chart on Asia - Market size and forecast 2022-2027 ($ billion)
• Exhibit 88: Data Table on Asia - Market size and forecast 2022-2027 ($ billion)
• Exhibit 89: Chart on Asia - Year-over-year growth 2022-2027 (%)
• Exhibit 90: Data Table on Asia - Year-over-year growth 2022-2027 (%)
• 9.6 Rest of World (ROW) - Market size and forecast 2022-2027
• Exhibit 91: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
• Exhibit 92: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
• Exhibit 93: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
• Exhibit 94: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
• 9.7 US - Market size and forecast 2022-2027
• Exhibit 95: Chart on US - Market size and forecast 2022-2027 ($ billion)
• Exhibit 96: Data Table on US - Market size and forecast 2022-2027 ($ billion)
• Exhibit 97: Chart on US - Year-over-year growth 2022-2027 (%)
• Exhibit 98: Data Table on US - Year-over-year growth 2022-2027 (%)
• 9.8 Germany - Market size and forecast 2022-2027
• Exhibit 99: Chart on Germany - Market size and forecast 2022-2027 ($ billion)
• Exhibit 100: Data Table on Germany - Market size and forecast 2022-2027 ($ billion)
• Exhibit 101: Chart on Germany - Year-over-year growth 2022-2027 (%)
• Exhibit 102: Data Table on Germany - Year-over-year growth 2022-2027 (%)
• 9.9 Canada - Market size and forecast 2022-2027
• Exhibit 103: Chart on Canada - Market size and forecast 2022-2027 ($ billion)
• Exhibit 104: Data Table on Canada - Market size and forecast 2022-2027 ($ billion)
• Exhibit 105: Chart on Canada - Year-over-year growth 2022-2027 (%)
• Exhibit 106: Data Table on Canada - Year-over-year growth 2022-2027 (%)
• 9.10 China - Market size and forecast 2022-2027
• Exhibit 107: Chart on China - Market size and forecast 2022-2027 ($ billion)
• Exhibit 108: Data Table on China - Market size and forecast 2022-2027 ($ billion)
• Exhibit 109: Chart on China - Year-over-year growth 2022-2027 (%)
• Exhibit 110: Data Table on China - Year-over-year growth 2022-2027 (%)
• 9.11 UK - Market size and forecast 2022-2027
• Exhibit 111: Chart on UK - Market size and forecast 2022-2027 ($ billion)
• Exhibit 112: Data Table on UK - Market size and forecast 2022-2027 ($ billion)
• Exhibit 113: Chart on UK - Year-over-year growth 2022-2027 (%)
• Exhibit 114: Data Table on UK - Year-over-year growth 2022-2027 (%)
• 9.12 Market opportunity By Geographical Landscape
• Exhibit 115: Market opportunity By Geographical Landscape ($ billion)
• Exhibit 116: Data Tables on Market opportunity By Geographical Landscape ($ billion)

10 Drivers, Challenges, and Trends

• 10.1 Market drivers
• 10.2 Market challenges
• 10.3 Impact of drivers and challenges
• Exhibit 117: Impact of drivers and challenges in 2022 and 2027
• 10.4 Market trends

11 Vendor Landscape

• 11.1 Overview
• 11.2 Vendor landscape
• Exhibit 118: Overview on Criticality of inputs and Factors of differentiation
• 11.3 Landscape disruption
• Exhibit 119: Overview on factors of disruption
• 11.4 Industry risks
• Exhibit 120: Impact of key risks on business

12 Vendor Analysis

• 12.1 Vendors covered
• Exhibit 121: Vendors covered
• 12.2 Market positioning of vendors
• Exhibit 122: Matrix on vendor position and classification
• 12.3 Abbott Laboratories
• Exhibit 123: Abbott Laboratories - Overview
• Exhibit 124: Abbott Laboratories - Business segments
• Exhibit 125: Abbott Laboratories - Key news
• Exhibit 126: Abbott Laboratories - Key offerings
• Exhibit 127: Abbott Laboratories - Segment focus
• 12.4 AbbVie Inc.
• Exhibit 128: AbbVie Inc. - Overview
• Exhibit 129: AbbVie Inc. - Product / Service
• Exhibit 130: AbbVie Inc. - Key news
• Exhibit 131: AbbVie Inc. - Key offerings
• 12.5 Aerogen Pharma Ltd.
• Exhibit 132: Aerogen Pharma Ltd. - Overview
• Exhibit 133: Aerogen Pharma Ltd. - Product / Service
• Exhibit 134: Aerogen Pharma Ltd. - Key offerings
• 12.6 AstraZeneca Plc
• Exhibit 135: AstraZeneca Plc - Overview
• Exhibit 136: AstraZeneca Plc - Product / Service
• Exhibit 137: AstraZeneca Plc - Key news
• Exhibit 138: AstraZeneca Plc - Key offerings
• 12.7 Boehringer Ingelheim International GmbH
• Exhibit 139: Boehringer Ingelheim International GmbH - Overview
• Exhibit 140: Boehringer Ingelheim International GmbH - Business segments
• Exhibit 141: Boehringer Ingelheim International GmbH - Key news
• Exhibit 142: Boehringer Ingelheim International GmbH - Key offerings
• Exhibit 143: Boehringer Ingelheim International GmbH - Segment focus
• 12.8 Celon Pharma SA
• Exhibit 144: Celon Pharma SA - Overview
• Exhibit 145: Celon Pharma SA - Business segments
• Exhibit 146: Celon Pharma SA - Key offerings
• Exhibit 147: Celon Pharma SA - Segment focus
• 12.9 Cipla Ltd.
• Exhibit 148: Cipla Ltd. - Overview
• Exhibit 149: Cipla Ltd. - Business segments
• Exhibit 150: Cipla Ltd. - Key news
• Exhibit 151: Cipla Ltd. - Key offerings
• Exhibit 152: Cipla Ltd. - Segment focus
• 12.10 F. Hoffmann La Roche Ltd.
• Exhibit 153: F. Hoffmann La Roche Ltd. - Overview
• Exhibit 154: F. Hoffmann La Roche Ltd. - Business segments
• Exhibit 155: F. Hoffmann La Roche Ltd. - Key news
• Exhibit 156: F. Hoffmann La Roche Ltd. - Key offerings
• Exhibit 157: F. Hoffmann La Roche Ltd. - Segment focus
• 12.11 GlaxoSmithKline Plc
• Exhibit 158: GlaxoSmithKline Plc - Overview
• Exhibit 159: GlaxoSmithKline Plc - Business segments
• Exhibit 160: GlaxoSmithKline Plc - Key news
• Exhibit 161: GlaxoSmithKline Plc - Key offerings
• Exhibit 162: GlaxoSmithKline Plc - Segment focus
• 12.12 Glenmark Pharmaceuticals Ltd.
• Exhibit 163: Glenmark Pharmaceuticals Ltd. - Overview
• Exhibit 164: Glenmark Pharmaceuticals Ltd. - Product / Service
• Exhibit 165: Glenmark Pharmaceuticals Ltd. - Key offerings
• 12.13 Lupin Ltd.
• Exhibit 166: Lupin Ltd. - Overview
• Exhibit 167: Lupin Ltd. - Product / Service
• Exhibit 168: Lupin Ltd. - Key news
• Exhibit 169: Lupin Ltd. - Key offerings
• 12.14 Novartis AG
• Exhibit 170: Novartis AG - Overview
• Exhibit 171: Novartis AG - Business segments
• Exhibit 172: Novartis AG - Key offerings
• Exhibit 173: Novartis AG - Segment focus
• 12.15 Sumitomo Pharma Co. Ltd.
• Exhibit 174: Sumitomo Pharma Co. Ltd. - Overview
• Exhibit 175: Sumitomo Pharma Co. Ltd. - Business segments
• Exhibit 176: Sumitomo Pharma Co. Ltd. - Key offerings
• Exhibit 177: Sumitomo Pharma Co. Ltd. - Segment focus
• 12.16 Teva Pharmaceutical Industries Ltd.
• Exhibit 178: Teva Pharmaceutical Industries Ltd. - Overview
• Exhibit 179: Teva Pharmaceutical Industries Ltd. - Business segments
• Exhibit 180: Teva Pharmaceutical Industries Ltd. - Key news
• Exhibit 181: Teva Pharmaceutical Industries Ltd. - Key offerings
• Exhibit 182: Teva Pharmaceutical Industries Ltd. - Segment focus
• 12.17 Vertex Pharmaceuticals Inc.
• Exhibit 183: Vertex Pharmaceuticals Inc. - Overview
• Exhibit 184: Vertex Pharmaceuticals Inc. - Product / Service
• Exhibit 185: Vertex Pharmaceuticals Inc. - Key offerings

13 Appendix

• 13.1 Scope of the report
• 13.2 Inclusions and exclusions checklist
• Exhibit 186: Inclusions checklist
• Exhibit 187: Exclusions checklist
• 13.3 Currency conversion rates for US$
• Exhibit 188: Currency conversion rates for US$
• 13.4 Research methodology
• Exhibit 189: Research methodology
• Exhibit 190: Validation techniques employed for market sizing
• Exhibit 191: Information sources
• 13.5 List of abbreviations
• Exhibit 192: List of abbreviations